Boosting stroke research through Mitacs Globalink

Severe brain damage induced by a stroke produces a reduction of immune functioning, which can result in fatal infections threatening the survival of patients after a stroke. Given that 20-25% of patients fall victim to infection post-stroke, this research is highly significant.

Globalink Professor Profile: Dr. Pierre Sullivan from UToronto

While much research exists to study large commercial airliners, micro-air vehicles remain under-studied by comparison. As Director of the Turbulence Research Lab at UofT, Dr. Sullivan is studying aerodynamic control of these aircraft flying at low speeds, with the goal of developing methods to improve their performance at minimal cost to manufacturers.

Revolutionizing breast cancer treatment

However, it is difficult for doctors to determine which patients are not responding to the drugs early in the process, so alternative treatment options can be tried.  As a result, patients can be over-treated, and unnecessarily suffer the side-effects of chemotherapy before realizing it is having little effect.

Masters student Xiaohui Wang at the Department of Computational Mathematics at the University of Waterloo set out to change this through a Mitacs-Accelerate internship with Ontario-based Rna Diagnostics.

Canadian pharmaceutical company given start-up strength

However, the cost of research and development of natural health products is often impossibly steep as the products must be rigorously tested and proven before they can be placed on store shelves.

With this challenge ahead of them, the Alberta “phyto-pharmaceutical” biotech company, SinoVeda, turned to Mitacs-Accelerate to assist in the advanced testing of its latest natural calcium supplement which is currently undergoing clinical trials.

Collaborating on a vaccine for cancer

The company is developing a novel cancer vaccine based on a specific antigen and needed the research expertise to help them understand, at a molecular level, how that antigen is expressed in different types of cancer. They turned to Dalhousie postdoctoral fellow Olga Hrytsenko for insight. Olga’s 17 years of molecular biology experience is the “perfect fit” for the project says Marianne Stanford, Director of Research, at Immunovaccine.

Award Winner Interview: SayedMasoud Hashemi Amroabadi

The research led to a 78% reduction in CT image noise which facilitates a corresponding decrease in the patient radiation exposure required for high quality CT images, saving patients from the potentially harmful effects of X-ray dose radiation.  Below is an exclusive interview with Mr. Hashemi, who won the Mitacs Award for Novelty in Application, as presented by the Honourable Gail Shea, Minister of National Revenue at the 2nd Annual Mitacs Awards Reception, held November 28th in Ottawa.

Award Winner Interview: Joanna Triscott

Because of this research, BC Children’s Hospital can how examine all new cases of pediatric brain tumors throughout the entirety of Western Canada with precision and accuracy – thus reducing the (often excessive) intensity of treatment for children with cancer while still effectively treating the disease.  Below is an exclusive interview with Ms.

Award Winner Interview: Oualid Haddad

The research led to the completion of a motorized incubator device that now enables researchers to observe live cells for days at a time as they are stretched under the microscope.  His work may help to cure a devastating skin blistering disease called epidermolysis bullosa simplex.  Below is an exclusive interview with Mr.

AllerGen boosts annual trainee event with Mitacs Step workshop

AllerGen’s 50+ trainees learned how to refresh, build and make the most of their existing networks at the Mitacs Step workshop.

Mitacs Accelerate partnership leads to development of high-tech diabetic insoles

By 2020, it is estimated that diabetes will cost the Canadian healthcare system $16.9 billion a year. In response, Calgary-based Orpyx Medical Technologies is developing a product that is garnering the attention of the diabetes technology community. The SurroSense Rx is a pressure sensitive insole that relays plantar pressure information to a wristwatch, notifying the user when damage is being done to their feet so that behavior can be modified to avoid complications.

Pages